Oracle Corporation (ORCL)

Add to Watchlists Create an Alert
34.23 +0.11  +0.32%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

Oracle Corporation R&D Expense Quarterly:

1.186B for Feb. 28, 2013
View Full Chart

Oracle Corporation R&D Expense Quarterly Chart

    Oracle Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Feb. 28, 2013 1.186B
    Nov. 30, 2012 1.199B
    Aug. 31, 2012 1.201B
    May 31, 2012 1.226B
    Feb. 29, 2012 1.145B
    Nov. 30, 2011 1.102B
    Aug. 31, 2011 1.05B
    May 31, 2011 1.17B
    Feb. 28, 2011 1.127B
    Nov. 30, 2010 1.119B
    Aug. 31, 2010 1.103B
    May 31, 2010 1.063B
    Feb. 28, 2010 823.00M
    Nov. 30, 2009 708.00M
    Aug. 31, 2009 660.00M
    May 31, 2009 730.00M
    Feb. 28, 2009 677.00M
    Nov. 30, 2008 651.00M
    Aug. 31, 2008 708.00M
    May 31, 2008 734.00M
    Feb. 29, 2008 Go Pro
    Nov. 30, 2007 Go Pro
    Aug. 31, 2007 Go Pro
    May 31, 2007 Go Pro
    Feb. 28, 2007 Go Pro
       
    Nov. 30, 2006 Go Pro
    Aug. 31, 2006 Go Pro
    May 31, 2006 Go Pro
    Feb. 28, 2006 Go Pro
    Nov. 30, 2005 Go Pro
    Aug. 31, 2005 Go Pro
    May 31, 2005 Go Pro
    Feb. 28, 2005 Go Pro
    Nov. 30, 2004 Go Pro
    Aug. 31, 2004 Go Pro
    May 31, 2004 Go Pro
    Feb. 29, 2004 Go Pro
    Nov. 30, 2003 Go Pro
    Aug. 31, 2003 Go Pro
    May 31, 2003 Go Pro
    Feb. 28, 2003 Go Pro
    Nov. 30, 2002 Go Pro
    Aug. 31, 2002 Go Pro
    May 31, 2002 Go Pro
    Feb. 28, 2002 Go Pro
    Nov. 30, 2001 Go Pro
    Aug. 31, 2001 Go Pro
    May 31, 2001 Go Pro
    Feb. 28, 2001 Go Pro
    Nov. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ORCL R&D Expense Quarterly Benchmarks

    Companies
    Microsoft Corporation 2.64B
    Apple 1.119B
    International Business Machines 1.644B

    ORCL R&D Expense Quarterly Rankings

    Overall 99th percentile
    20 of 8006
    Sector 99th percentile
    9 of 952 in Technology
    Industry 94th percentile
    2 of 35 in Software - Infrastructure

    ORCL R&D Expense Quarterly Range, Past 5 Years

    Minimum 651.00M Nov 2008
    Maximum 1.226B May 2012
    Average 969.10M